Connect with us

Hi, what are you looking for?

Deluxe Investment GroupDeluxe Investment Group

Investing

White House pulls nomination of David Weldon as CDC director

The White House is pulling the nomination of Dave Weldon for Centers for Disease Control and Prevention (CDC) director, Fox News Digital has confirmed. Weldon was expected to have his confirmation hearing on Thursday.

The Senate Health, Education, Labor, and Pensions (HELP) Committee announced that it canceled its hearing in a statement on Thursday morning. However, it confirmed that lawmakers would still vote on the nominations of Dr. Jay Bhattacharya for National Institutes of Health (NIH) director and Dr. Marty Makary for Commissioner of the U.S. Food and Drug Administration.

‘It became clear that the votes weren’t there in the Senate for him to get confirmed. This would have been a futile effort,’ a source familiar with the nomination told Fox News Digital. However, there is no official reason for pulling the nomination at this time.

The Wall Street Journal reported that Weldon was unaware that his nomination had been pulled until he reached the Capitol on Thursday morning. However, Fox News Digital’s source said Weldon was told last night.

Weldon, a medical doctor and former Florida congressman, has made statements against vaccines in the past, which were expected to be brought up during his hearing. In a 2007 statement, Weldon said there were ‘legitimate questions’ about potential links between vaccines and childhood neurodevelopmental disorders, such as autism.

Additionally, during his time in Congress, he introduced legislation with former Rep. Carolyn Maloney, D-Ny., that would have banned mercury from vaccines.

The question of vaccine skepticism came up repeatedly during now-HHS Secretary RFK Jr.’s confirmation hearing. Democrats on the Senate HELP Committee repeatedly brought up Kennedy’s claims linking vaccines to autism.

They also asked about his time serving as chairman and chief litigation counsel, for Children’s Health Defense, a nonprofit organization that has advocated against vaccines and sued the federal government numerous times.

Fox News Channel’s Peter Doocy and Fox News Digital’s Paul Steinhauser contributed to this report.

This post appeared first on FOX NEWS

Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!



    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    You May Also Like

    Latest News

    Sister Stephanie Schmidt had a hunch about what her fellow nuns would discuss over dinner at their Erie, Pennsylvania, monastery on Wednesday night. The...

    Latest News

    In the final three weeks of the presidential race, former president Donald Trump and his advisers have attacked one particular foe more than three...

    Latest News

    “And there’s very few states that benefit like you do from fracking. I mean, you have 500,000 jobs.” — Former president Donald Trump, remarks...

    Latest News

    A former deputy Palm Beach County sheriff who fled to Moscow and became one of the Kremlin’s most prolific propagandists is working directly with...

    Disclaimer: Deluxeinvestmentgroup.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 deluxeinvestmentgroup.com